The information presented in this section concerns both Icade Santé (healthcare assets held in France) and Icade Healthcare Europe (healthcare assets held internationally).
Filter by
Results notice EUR 500M 0.875 per cent Notes due 2029
27 Jul 2021
PDF - 298 Kb
Approbation of the change of Icade Santé corporate form and other amendments to the by-laws
27 Jul 2021
PDF - 671 Kb
Icade Santé : half-year results 2021
26 Jul 2021
PDF - 684 Kb
Condensed consolidated financial statements as of June 30, 2021
26 Jul 2021
PDF - 1,3 Mb
Consultation of the noteholders in the context of the contemplated initial public offering of Icade Santé
9 Jul 2021
PDF - 672 Kb
Report of the shareholders
9 Jul 2021
PDF - 381 Kb
Notice of meeting of noteholders MEUR 500 0.875 per cent Notes due 2029
9 Jul 2021
PDF - 547 Kb
Icade Santé acquires a PAC facility from Orpea for €28M
1 Jul 2021
PDF - 617 Kb
Icade Santé acquires another four facilities in France
23 Jun 2021
PDF - 650 Kb
Handover of four facilities for a total investment of €76M, liquidity event : IPO currently the preferred option, a CFO appointed
7 Jun 2021
PDF - 770 Kb
Consolidated financial statements 2020
22 Feb 2021
PDF - 1,4 Mb
Press Release - 2020 Full Year Results
22 Feb 2021
PDF - 706 Kb
Icade's Healthcare Property portfolio continues to grow with €163M in new investments in Italy and France
21 Dec 2020
PDF - 770 Kb
Icade Santé acquires the real estate of the Navarre polyclinic
5 Nov 2020
PDF - 730 Kb
Icade Santé - Social Bond Final Prospectus
16 Sep 2020
PDF - 3,4 Mb
Icade Santé, Places that care for people
Contact us